US 9969799B2
· Wang et al.
· 2018
[cited by applicant]
US 20110027297A1
· Sahin et al.
· 2011
[cited by applicant]
US 20210122817A1
· Kong et al.
· 2021
[cited by applicant]
US 20240076362A1
· Sun et al.
· 2024
[cited by applicant]
CN 101001879A
· 2007
[cited by applicant]
CN 101998992A
· 2011
[cited by applicant]
CN 105759057A
· 2016
[cited by applicant]
CN 105969901A
· 2016
[cited by applicant]
WO WO2002062946A2
· 2002
[cited by applicant]
WO WO2003035689A1
· 2003
[cited by applicant]
WO WO2005040796A1
· 2005
[cited by applicant]
WO WO2005123779A2
· 2005
[cited by applicant]
WO WO2008068048A2
· 2008
[cited by applicant]
WO WO2011147851A1
· 2011
[cited by applicant]
WO WO2017143036A1
· 2017
[cited by applicant]
WO WO2019152706A1
· 2019
[cited by applicant]
WO WO2019152715A1
· 2019
[cited by applicant]
WO WO2020160468A1
· 2020
[cited by applicant]
WO WO2021022083A2
· 2021
[cited by applicant]
WO WO2021081101A1
· 2021
[cited by applicant]
WO WO2024086796A1
· 2024
[cited by applicant]
Edwards et al., The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, BLyS. J Mol Biol. Nov. 14, 2003;334(1):103-18. (Year: 2003).
[cited by examiner]
Allen, M., et al., “Novel late-onset Alzheimer disease loci variants associate with brain gene expression,”
[cited by applicant]
Antúnez, C., et al., “The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease,”
[cited by applicant]
Arnett, M.J., et al., “Pro-NGF, Sortilin, and p75
[cited by applicant]
Barber, R.C., “The Genetics of Alzheimer's Disease,”
[cited by applicant]
Beattie, M.S., et al., “ProNGF Induces p75-mediated Death of Oligodendrocytes Following Spinal Cord Injury,”
[cited by applicant]
Bubien, J.K., et al., “Transfection of the CD20 Cell Surface Molecule Into Ectopic Cell Types Generates a Ca2+ Conductance Found Constitutively in B Lymphocytes,”
[cited by applicant]
Cruse, G., et al., “The CD20 Homologue MS4A4 Directs Trafficking of KIT Toward Clathrin-independent Endocytosis Pathways and Thus Regulates Receptor Signaling and Recycling,”
[cited by applicant]
Efthymiou, A.G., and Goate A.M., “Late Onset Alzheimer's Disease Genetics Implicates Microglial Pathways in Disease Risk,”
[cited by applicant]
Elias-Sonnenschein, L.S., et al., “Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort,”
[cited by applicant]
Fahnestock, M., et al., “The Precursor Pro-nerve Growth Factor is the Predominant Form of Nerve Growth Factor in Brain and is Increased in Alzheimer's Disease,”
[cited by applicant]
Fan, Y.J., et al., “Differential Effects of Pro-BDNF on Sensory Neurons After Sciatic Nerve Transection in Neonatal Rats,”
[cited by applicant]
Greer, P.L., et al., “A Family of Non-GPCR Chemosensors Defines an Alternative Logic for Mammalian Olfaction,”
[cited by applicant]
Harrington, A.W., et al., “Secreted ProNGF is a Pathophysiological Deat-inducing Ligand After Adult CNS Injury,”
[cited by applicant]
Hollingworth, P., et al., “Common Variants at ABCA7, MS4A6AIMS4A4E, EPHA1, CD33 and CD2AP Are Associated With Alzheimer's Disease,”
[cited by applicant]
Hu, X., et al., “Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment,”
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2019/016141, Korean Intellectual Property Office, Korea, mailed on May 30, 2019, 11 pages.
[cited by applicant]
Ishibashi, K., et al., “Identification of a New Multigene Four-transmembrane Family (MS4A) Related to CD20, HTm4 and β Subunit of the High-affinity IgE Receptor,”
[cited by applicant]
Jansen, P., et al., “Roles for the Pro-neurotrophin Receptor Sortilin in Neuronal Development, Aging and Brain Injury,”
[cited by applicant]
Karch, C.M., et al., “Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains,”
[cited by applicant]
Karch, C.M., et al., “Alzheimer's disease risk genes and mechanisms of disease pathogenesis,”
[cited by applicant]
Kay, B.K., et al., “The Importance of Being Proline: the Interaction of Proline-rich Motifs in Signaling Proteins With Their Cognate Domains,”
[cited by applicant]
Koslowski, M., et al., “MS4A12 is a Colon-selective Store-operated Calcium Channel Promoting Malignant Cell Processes,”
[cited by applicant]
Lacher, S.E., et al., “A Hypermorphic Antioxidant Response Element is Associated With Increased MS4A6A Expression and Alzheimer's Disease,”
[cited by applicant]
Lambert, J.C., et al., “Meta-analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer's Disease,”
[cited by applicant]
Liang, C.C., et al., “In Vitro Scratch Assay: a Convenient and Inexpensive Method for Analysis of Cell Migration in Vitro,”
[cited by applicant]
Liang, Y., and Tedder, T.F., “Identification of a CD20-, FcεRIβ-, and HTm4-related Gene Family: Sixteen New MS4A Family Members Expressed in Human and Mouse,”
[cited by applicant]
Ma, J., et al., “MS4A Cluster in Alzheimer's Disease,”
[cited by applicant]
Ma, J., et al., “MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures,”
[cited by applicant]
Maximov, A., et al., “Monitoring Synaptic Transmission In Primary Neuronal Cultures Using Local Extracellular Stimulation,”
[cited by applicant]
Naj, A.C., et al., “Common Variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHAI Are Associated With Late-onset Alzheimer's Disease,”
[cited by applicant]
Nakamura, K., et al., “Intracellular Sortilin Expression Pattern Regulates ProNGF-induced Naturally Occurring Cell Death During Development,”
[cited by applicant]
Nykjaer, A., et al., “Sortilin is Essential for ProNGF-induced Neuronal Cell Death,”
[cited by applicant]
Nykjaer, A., et al., “p75
[cited by applicant]
Proitsi, P., et al. “Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood,”
[cited by applicant]
Provenzano, M.J., et al., “p75
[cited by applicant]
Shawi, R.A., et al., “Neurotoxic and Neurotrophic Roles of ProNGF and the Receptor Sortilin in the Adult and Ageing Nervous System,”
[cited by applicant]
Teng, H.K., et al., “ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75
[cited by applicant]
Volosin, M., et al., “Induction of Proneurotrophins and Activation of p75
[cited by applicant]
Volosin, M., et al., “Interaction of Survival and Death Signaling in Basal Forebrain Neurons: Roles of Neurotrophins and Proneurotrophins,”
[cited by applicant]
Wei, Y., et al., “Enhanced Protein Expressions of Sortilin and p75
[cited by applicant]
Yano, H., et al., “Proneurotrophin-3 Is a Neuronal Apoptotic Ligand:Evidence for Retrograde-Directed Cell Killing,”
[cited by applicant]
Chen, C., et al., “Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations,” EMBO Journal 14(12):2784-2794, Oxford University Press, Un…
[cited by applicant]
Deming, Y., et al., “The MS4A gene cluster is a key regulator of soluble TREM2 and Alzheimer disease risk,”
[cited by applicant]
Denardo, D.G., et al., “Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy,”
[cited by applicant]
Dondelinger, M., et al., “Understanding the Significance and Implications of Antibody Numbering and Antigen-Binding Surface/Residue Definition,” Front Immunol 9:2278, Frontiers Media SA., Switzerland (Oct. 2018).
[cited by applicant]
Drake, A.W., and Klakamp, S.L., “A Rigorous Multiple Independent Binding Site Model for Determining Cell-based Equilibrium Dissociation Constants,”
[cited by applicant]
Engle, S.J., et al., “Best Practices For Translational Disease Modeling Using Human iPSC-derived Neurons,”
[cited by applicant]
He Li, W., “Research progress in MS4A gene family and tumor,” Tumor 36:345-350, China Academic Journal Electronic Publishing House, China (Mar. 2016).
[cited by applicant]
He Li, W., “Research progress on MS4A gene family and clinically relevant diseases,” Chin J Clin Lab Sci 34(3):202-204, Chinese Medical Journals Publishing House, China (Mar. 2016).
[cited by applicant]
Idusogie, E.E., et al., “Mapping of the Clq Binding Site on Rituxan, A Chimeric Antibody with a Human IgG1 Fc,”
[cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2019/016156, European Patent Office, Netherlands, mailed on Apr. 23, 2019, 13 pages.
[cited by applicant]
International Search Report and Written Opinion mailed Jan. 28, 2021, in Application No. PCT/US2020/044335, EPO, Netherlands, 15 pages.
[cited by applicant]
International Search Report for International Application No. PCT/US2019/016141, Korean Intellectual Property Office, Republic of Korea, mailed May 20, 2019, 11 pages.
[cited by applicant]
Koenig, P., et al., “Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding,”
[cited by applicant]
Kuek, L.E., et al., “The MS4A family: counting past 1, 2 and 3,”
[cited by applicant]
Kussie, P.H., et al., “A Single Engineered Amino Acid Substitution Changes Antibody Fine Specificity,” Journal of Immunology 152(1):146-152, American Association of Immunology, United States (1994).
[cited by applicant]
Morris, G.E., “Epitope Mapping of Protein Antigens by Competition ELISA,” The Protein Protocols Handbook, pp. 595-600, Humana Press, United States (1996).
[cited by applicant]
Murthy, M.N., et al., “Increased Brain Expression of GPNMB Is Associated with Genome Wide Significant Risk for Parkinson's Disease on Chromosome 7p15.3,”
[cited by applicant]
Office Action mailed Feb. 28, 2022, in U.S. Appl. No. 16/965,676, Kong, P., et al., filed Jul. 29, 2020, 16 pages.
[cited by applicant]
Office Action mailed Jun. 16, 2022, in U.S. Appl. No. 16/943,123, Sun, J., et al., filed Jul. 30, 2020, 7 pages.
[cited by applicant]
Office Action mailed Oct. 18, 2021 in U.S. Appl. No. 16/943,123, Sun, J., et al., filed Jul. 30, 2020, 15 pages.
[cited by applicant]
Office Action mailed Oct. 3, 2022, in U.S. Appl. No. 16/943,123, Sun, J., et al., filed Jul. 30, 2020, 3 pages.
[cited by applicant]
Peng, X., et al., “Preclinical Evaluation of 3D185, a Novel Potent Inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-Dependent and Macrophage-Dominant Cancer models,”
[cited by applicant]
Piccio, L., et al., “Cerebrospinal Fluid Soluble TREM2 is Higher in Alzheimer Disease and Associated With Mutation Status,”
[cited by applicant]
Pocock, J.M., et al., “Modelling Microglial Function With Induced Pluripotent Stem Cells: An Update,”
[cited by applicant]
Puri, M., et al., “The Evaluation of MS4A4A and MS4A8B Expression in Hematopoietic Cells,” retrieved from: https://prism.ucalgary.ca/bitstream/handle/11023/1791/ucalgary2014purmandip.pdf;jsessionid=cda23b615634fb7f5836e…
[cited by applicant]
Reitz, C., “Toward Precision medicine in Alzheimer's Disease,” Ann. Transl. Med 4(6):107, 7 pages, AME Publishing Corp, United States (2016).
[cited by applicant]
Rudikoff, S., et al., “Single amino acid substitution altering antigen-binding specificity,” Proc Natl Acad Sci USA 79(6):1979-1983, National Academy of Sciences, United States (Mar. 1982).
[cited by applicant]
Salimi, A., et al., “Comparison Of Different Protocols For Neural Differentiation Of Human Induced Pluripotent Stem Cells,”
[cited by applicant]
Sanyal, R., et al., “MS4A4A: a novel cell surface marker for M2 macrophages and plasma cells,”
[cited by applicant]
Sekine, S. “The Current State and the Issues of Antibody Drugs,”
[cited by applicant]
Sela-Culang, I., et al., “The structural basis of antibody-antigen recognition,” Front Immunol 4:302, Frontiers Media SA., Switzerland (Oct. 2013).
[cited by applicant]
Shang, L., et al., “Selective Antibody Intervention of Toll-like Receptor 4 Activation through Fc γ Receptor Tethering,”
[cited by applicant]
Shih-Feng, Y., et al., “MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state,” MedRxiv 10.1101/2023.02.06.23285545, accessed at https://www.medrixi…
[cited by applicant]
Stanford Health Now, “Alzheimer's Prevention, Treatment and Research—A Q&A with Dr. Frank Longo,” retrieved from: stanfordhealthcare.org/Stanford-health-now/2016/alzheimers-prevention-treatment-research-qa-longo.html, a…
[cited by applicant]
TCW, J., et al., “An Efficient Platform For Astrocyte Differentiation From Human Induced Pluripotent Stem Cells,”
[cited by applicant]
Thornton, P., et al., “TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant,”
[cited by applicant]
Tomay, F., “Regulation and function of the tetraspanin-like molecule MS4A4A in alternatively activated and tumor-associated macrophages,” XP055578452, Retrieved from the Internet: https://air.unimi.it/retrieve/handle/24…
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2023/077418, European Patent Office, Netherlands, mailed Feb. 12, 2024, 11 pages.
[cited by applicant]
NCBI, “Membrane-spanning 4-domains subfamily A member 4A isoform 1 [
[cited by applicant]